1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/21507
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSasadeusz, Joe-
dc.contributor.authorGrigg, Andrew P-
dc.contributor.authorHughes, Peter D-
dc.contributor.authorLim, Seng Lee-
dc.contributor.authorLucas, Michaela-
dc.contributor.authorMcColl, Geoff-
dc.contributor.authorMcLachlan, Sue Anne-
dc.contributor.authorPeters, Marion G-
dc.contributor.authorShackel, Nicholas-
dc.contributor.authorSlavin, Monica-
dc.contributor.authorSundararajan, Vijaya-
dc.contributor.authorThompson, Alexander-
dc.contributor.authorDoyle, Joseph-
dc.contributor.authorRickard, James-
dc.contributor.authorDe Cruz, Peter P-
dc.contributor.authorGish, Robert G-
dc.contributor.authorVisvanathan, Kumar-
dc.date2019-06-06-
dc.date.accessioned2019-08-12T05:01:10Z-
dc.date.available2019-08-12T05:01:10Z-
dc.date.issued2019-08-
dc.identifier.citationClinics in Liver Disease 2019; 23(3): 511-519en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/21507-
dc.description.abstractPatients with malignancies require chemotherapy and other immunosuppressive therapies for treatment. Because of this immunosuppression, in patients who have ever been exposed to hepatitis B it is possible for reactivation to occur. This reactivation can be fatal. Reactivation is particularly likely in patients who receive B cell-active agents such as rituximab. The occurrence of reactivation flares may also delay further chemotherapy, which can negatively affect the outcome of the underlying malignancy. Accordingly, it is important to screen patients for markers of hepatitis B and institute antiviral prophylaxis to prevent reactivation.en_US
dc.language.isoeng-
dc.subjectCanceren_US
dc.subjectHematological malignancyen_US
dc.subjectHepatitis Ben_US
dc.subjectProphylaxisen_US
dc.subjectReactivationen_US
dc.subjectRituximaben_US
dc.subjectSolid tumorsen_US
dc.titleScreening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleClinics in Liver Diseaseen_US
dc.identifier.affiliationUniversity of Western Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australiaen_US
dc.identifier.affiliationVictorian Comprehensive Cancer Centre, 305 Grattan Street, Melbourne, Victoria 3000, Australiaen_US
dc.identifier.affiliationDepartment of Public Health, La Trobe University, Plenty Road, Bundoora, Victoria 3086, Australiaen_US
dc.identifier.affiliationBurnet Institute, 85 Commercial Road, Melbourne, Victoria 3004, Australiaen_US
dc.identifier.affiliationThe Alfred and Monash University, 85 Commercial Road, Melbourne, Victoria 3004, Australiaen_US
dc.identifier.affiliationSt Vincent's Hospital, 41 Victoria Street, Fitzroy, Victoria 3065, Australiaen_US
dc.identifier.affiliationRoyal Melbourne Hospital, 300 Grattan Street, Parkville, Victoria 3050, Australiaen_US
dc.identifier.affiliationUniversity of Melbourne, Grattan Street, Parkville, Victoria 3010, Australiaen_US
dc.identifier.affiliationPeter Doherty Institute for Infection and Immunity, Elizabeth Street, Melbourne, Victoria 3000, Australiaen_US
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen_US
dc.identifier.affiliationIngham Institute, 1 Campbell Street, Liverpool, Sydney, North South Wales 2170, Australiaen_US
dc.identifier.affiliationUniversity of Queensland Oral Health Centre, 288 Herston Road, Queensland 4006, Australiaen_US
dc.identifier.affiliationNational University of Singapore, 21 Lower Kent Ridge Road, Singapore 119077, Singaporeen_US
dc.identifier.affiliationUniversity of California, San Francisco, S357 Parnassus Avenue, San Francisco, CA 94143, USAen_US
dc.identifier.affiliationDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USAen_US
dc.identifier.affiliationAustin Healthen_US
dc.identifier.doi10.1016/j.cld.2019.04.011en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-3399-7236en_US
dc.identifier.pubmedid31266624-
dc.type.austinJournal Article-
dc.type.austinReview-
local.name.researcherDe Cruz, Peter P
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptClinical Haematology-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Dec 30, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.